Phase II study of nab-paclitaxel and carboplatin with concurrent thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer

Phase 2

• Conditions: on-small cell lung cancer

• Registration Number: JPRN-UMIN000011681
• Lead Sponsor: Gifu Municipal Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-09-09
• Study Completion: 2017-08-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

Not provided

Exclusion Criteria

1)Active double cancer. 2)Active infections requiring systemic treatment. 3)Serious complications(e.g. heart failure, renal failure, hepatic failure, haemorrhagic peptic ulcer, intestinal paralysis, intestinal obstruction or poorly controlled diabetes) 4)Grade2 or higher peripheral neuropathy. 5)Positive HBs antigen and/or HCV antibody. 6)History of severe drug allergy. 7)History of hypersensivity for albumin-containing agents. 8)Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers.Males that are currently attempting to produce a pregnancy. 9)Judged ineligible by physicians for participation in the study from a safety viewpoint.

Study & Design

• Study Type: Interventional
• Study Design: Not specified